Cargando…
Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease
Sphingolipids are potent bioactive agents involved in the pathogenesis of various respiratory bacterial infections. To date, several sphingolipid derivatives are known, but S1P (Sphingosine-1-phosphate) and Ceramide are the best-studied sphingolipid derivatives in the context of human diseases. Thes...
Autores principales: | Prakash, Hridayesh, Upadhyay, Dilip, Bandapalli, Obul Reddy, Jain, Aklank, Kleuser, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605809/ https://www.ncbi.nlm.nih.gov/pubmed/33147503 http://dx.doi.org/10.1016/j.prostaglandins.2020.106504 |
Ejemplares similares
-
The Enigma of Sphingolipids in Health and Disease
por: Kleuser, Burkhard
Publicado: (2018) -
Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective
por: Sharma, Lalita, et al.
Publicado: (2017) -
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
por: Roy, Roshan Kumar, et al.
Publicado: (2021) -
Sphingolipids, mycobacteria and host: Unraveling the tug of war
por: Mohammed, Shakeel Ahmed, et al.
Publicado: (2022) -
Editorial: Sphingolipids in Infection Control
por: Seibel, Jürgen, et al.
Publicado: (2021)